Honigman Advises Nuwellis on its $5.0 Million Underwritten Public Offering

Honigman represented Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company, in a public offering of 2,580,667 shares of its Common Stock, pre-funded warrants to purchase 14,085,998 shares of Common Stock, Series A Warrants to purchase 49,999,995 shares of Common Stock and Series B Warrants to purchase 16,666,665 shares of Common Stock for gross proceeds of approximately $5.0 million.